octamethylcyclotetrasiloxane | CAS:556-67-2

We serve octamethylcyclotetrasiloxane CAS:556-67-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
octamethylcyclotetrasiloxane
Chemical Name:octamethylcyclotetrasiloxane
CAS.NO:556-67-2
Synonyms:Octamethylcyclotetrasiloxane; Cyclotetrasiloxane, octamethyl-; 2,2,4,4,6,6,8,8-octamethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane;
Molecular Formula:C8H24O4Si4
Molecular Weight:296.61600
 
Physical and Chemical Properties:
Density:0.956;
Melting point:17-18oC;
Boiling point:175-176oC;
Flash point:140oF;
Index of Refraction:1.3968;
 
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is a cyclic organic silicon substance which can be used as monomer in the production of silicone polymers such as rubber, resins and greases.



Contact us for information like octamethylcyclotetrasiloxane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2,4,4,6,6,8,8-octamethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,octamethyl- Use and application,2,2,4,4,6,6,8,8-octamethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane technical grade,usp/ep/jp grade.


Related News: API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine.1-Indanamine manufacturer Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.1-Chlorohexadecane supplier A key publication in a preclinical model demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643).(Diacetoxyiodo)benzene vendor The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.